Functional properties of agmatine in rat vas deferens

European Journal of Pharmacology

Volumn 307, Issue 3, 1996, Pages 299-304

  Jurkiewicz, Neide Hyppolito ^a   Garcez Do Carmo, Lucia ^a   Hirata, Hanako ^a   Da Costa Santos, Wilson ^a   Jurkiewicz, Aron ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adrenoceptor; Agmatine; Imidazoline receptor; Neurotransmission; Noradrenaline; Vas deferens

Indexed keywords

ADRENERGIC RECEPTOR; AGMATINE; IMIDAZOLINE RECEPTOR;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ELECTROSTIMULATION; FEMALE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; VAS DEFERENS;

EID: 0030568714     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00274-9     Document Type: Article

References (23)

1. Bylund, D.B., D.C. Eikenberg, J. Paul Hiebe, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman, P.B. Molinoff, R.R. Ruffolo, Jr. and U. Trendelenburg, 1994. IV. International Union of Pharmacology Nomenclature of Adrenoceptors, Pharmacol. Rev. 46, 121.
2. Caricati Neto, A., M. Sette and A. Jurkiewicz, 1992, Increased density of alpha-adrenoceptors in vas deferens of spontaneously hypertensive rats (SHR), indicated by functional and receptor binding studies, Eur. J. Pharmacol. 218, 51.
3. Diaz-Toledo, A. and Jurkiewicz. A., 1990, Estimation of dissociation constants and relative efficacies through the functional antagonism of beta-adrenoceptor agonists vs. transmural stimulation in rat vas deferens, Eur. J. Pharmacol. 191, 157.
4. Diaz-Toledo, A. and A. Jurkiewicz, 1991, Different mechanisms of action of agents acting on beta-adrenoceptors in barium-stimulated and electrically-stimulated rat vas deferens, Br. J. Pharmacol. 104, 277.
5. Drew, G.M., 1977, Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens, Eur. J. Pharmacol. 42, 123.
6. Furchgott, R.F., 1972, The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory, in: Catecholamines, eds. H. Blaschko and E. Muscholl (Springer Verlag, New York) p. 283.
7. Garcez do Carmo, L., A. Albillos, A.R. Artelejo, M.D. Fuente, M.G. Lopez, L. Gandia, P. Michelena and A.G. Garcia, 1993, R. 56865 inhibits catecholamine release from bovine chromaffin cells by blocking calcium channels. Br.J.Pharmacol. 110, 1149.
8. Garcez do Carmo, L., S.S. Lafayette, O.C. Azevedo, P. Michelena, A.G. Garcia, N.H. Jurkiewicz and A. Jurkiewicz, 1994, Changes on the ability of KCI to release neurotransmitters after unilateral vasectomy of the rat vas deferens, Abstracts XIV Latinamerican Congress of Pharmacology, Santiago. Chile, p. 133 [abstract].
9. Jurkiewicz., A. and N.H. Jurkiewicz, 1976, Dual effect of alpha-adrenoceptor antagonists in rat isolated vas deferens, Br. J. Pharmacol. 56, 169.
10. Jurkiewicz, N.H. and A. Jurkiewicz, 1991, Release of contractile agents from rat vas deferens by clonidine, Life Sci. 49, 1643.
11. Jurkiewicz, N.H., A. Jurkiewicz and A.G. Garcia, 1991, Reinnervation of the transplanted vas deferens: differential recovery of various biochemical and pharmacological parameters, J. Neural Transm. 85, 83.
12. Jurkiewicz, N.H., A.G. Garcia and A. Jurkiewicz, 1992, In vitro denervation of the rat vas deferens through hypothermic storage, Br. J. Pharmacol. 107, 610.
13. Langeloh, A. and A. Jurkiewicz, 1982, Analysis of the effects of Dopamine and Noradrenaline in relation to the proposed postsynaptic dopamine receptor in rat vas deferens, Naunyn Schmiedeberg's Arch. Pharmacol. 318, 202.
14. Li, G., S. Regunathan, C.J. Barrow, J. Eshraghi, R. Cooper and D.J. Reis, 1994, Agmatine: an endogenous clonidine displacing substance in the brain, Science 263, 966.
15. 2 and affinity constants for pharmacological competitive antagonists be estimated? J. Pharm. Pharmacol. 30, 312.
16. 2 imidazoline binding sites, Naunyn Schmiedeberg's Arch. Pharmacol. 351, 507.
17. Piletz, J.E., D.N. Chikkala and P. Elsberger, 1995, Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors, J. Pharmacol. Exp. Ther. 272, 581.
18. 2-adrenoceptor binding sites but neither activates nor inhibits atpha2-adrenoceptors, Naunyn Schmiedeberg's Arch. Pharmacol. 351, 10.
19. 1L adrenoceptors in rat vas deferens, An. Acad. Bras. Ci. 67, 267.
20. Raasch, W., S. Regunathan, G. Li and D.J. Reis, 1995, Agmatine, the bacterial amine, is widely distributed in mammalian tissues, Life Sci. 56, 2319.
21. Sun, M.K., S. Regunathan and D.J. Reis, 1995, Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat, Clin. Exp. Hypertens. 17, 115.
22. Szabo, B., R. Urban, N. Limberger and K. Starke, 1995, Cardiovascular effects of agmatine, a 'clonidine displacing substance', in concious rabbits, Naunyn Schmiedeberg's Arch. Pharmacol. 351, 268.
23. Vladimirova, I., N.H. Jurkiewicz and A. Jurkiewicz, 1994, Evidence for participation of nitric oxide in excitatory neurotransmission in rat vas deferens. Life Sci. 55, 1123.